Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Sell
50,301
-2,640
-5% -$941K 0.71% 31
2025
Q4
$17.3M Buy
52,941
+41,474
+362% +$13.2M 0.71% 26
2025
Q3
$3.24M Sell
11,467
-354
-3% -$103K 0.14% 80
2025
Q2
$3.3M Sell
11,821
-62
-0.5% -$17.6K 0.16% 72
2025
Q1
$3.7M Sell
11,883
-185
-2% -$54.6K 0.2% 58
2024
Q4
$3.15M Buy
12,068
+528
+5% +$157K 0.18% 70
2024
Q3
$3.72M Buy
11,540
+964
+9% +$315K 0.21% 54
2024
Q2
$3.3M Buy
10,576
+9,770
+1,212% +$2.87M 0.21% 50
2024
Q1
$229K Sell
806
-21
-3% -$6.14K 0.02% 205
2023
Q4
$238K Buy
827
+42
+5% +$11.4K 0.02% 183
2023
Q3
$211K Buy
+785
New +$196K 0.02% 172

Other funds holding AMGN

JB Capital's AMGN Position: Q1 2026 in Review

JB Capital reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $941K and leaving 50,301 shares worth $17.7M. The position accounts for 0.71% of the portfolio, ranked #31.

JB Capital first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • JB Capital held 50,301 shares of Amgen worth $17.7M as of Q1 2026.
  • JB Capital sold 2,640 Amgen shares in Q1 2026, an estimated $941K.
  • Amgen made up 0.71% of JB Capital's portfolio in Q1 2026, its #31 holding.
  • JB Capital first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on JB Capital's 13F filing for Q1 2026, filed 27 Apr 2026.